JAK2 and essential thrombocythemia: As a result, the JAK2 V617F cells specifically exhibited an enhanced differentiation into megakaryocytes following the induction with PMA, similar to what is observed in patients with ET, a condition typically associated with the heterozygous JAK2p.V617F mutation.